- ￥5733
- Biorbyt
- 英国
- orb1906864
- 2026年08月06日
企业认证
相关产品推荐更多 >
STRADA Peptide - middle region 蛋白，orb1997870，Biorbyt
￥2340
ZNF780A Peptide - N-terminal region 蛋白，orb2008282，Biorbyt
￥3692
CAP1 Peptide - N-terminal region 蛋白，orb2014964，Biorbyt
￥2340
PRKCA Peptide - middle region 蛋白，orb2001290，Biorbyt
￥2340
Human adenovirus C serotype 5 E1B 55 kDa Protein蛋白，orb1476939，biorbyt
￥5590
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AJE 润色服务限时 8 折起，权威机构信任 15+ 年Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
详询
- 保质期：
6 months from date of receipt.
- 英文名：
Recombinant Human Ankyrin-1/ANK1
- 库存：
99
- 供应商：
Biorbyt
- 规格：
50 ug
描述: Recombinant Human Ankyrin-1/ANK1 is produced by E. coli. The target gene encodingD589-F895 is expressed with a His tag at the C-terminus.
别名: Ankyrin-1; ANK-1; ANK1; ANK; Ankyrin-R; Erythrocyte ankyrin
生物来源: Human
表达区域: D589-F895
表达系统: E. coli
标签: C-His
UniProt ID: P16157
保存条件: Store at ≤-70°C, stable for 6 months after receipt. Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.
备注: For research use only.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Construction of Recombinant Human Cytomegalovirus
The use of reverse genetics to generate recombinant viruses allows the researcher to investigate the exact functional significance of particular viral genes during the virus life cycle, by means of their deletion or modification in the viral
Delivery of Recombinant Adenoviruses to Human Saphenous Vein
The human saphenous vein is the most commonly used conduit for coronary artery bypass grafting owing to its ready availability, ease of harvesting, and favorable surgical handling (1 ). However, it suffers from a progressive decline
Recombinant Genetic Libraries and Human Monoclonal Antibodies
In order to comprehensively manipulate the human proteome we require a vast repertoire of pharmacological reagents. To address these needs we have developed repertoires of synthetic antibodies by phage display, where diversified
技术资料暂无技术资料 索取技术资料
